Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 54, 2020 - Issue 3
Journal homepage
1,758
Views
11
CrossRef citations to date
0
Altmetric
Articles

Set-up and preliminary results from the Patient-overview Prostate Cancer. Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden

Ingela Franck LissbrantDepartment of Oncology, Institute of Clinical Sciences, The Sahlgrenska Academy, Goteborg, Sweden; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-8612-9814View further author information
ORCID Icon,
Marie Hjälm ErikssonDepartment of Oncology, S:t Göran Hospital, Stockholm, Sweden; View further author information
,
Mats LambeDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; ;Regional Cancer Centre Uppsala Örebro, Uppsala University Hospital, Uppsala, Sweden; View further author information
,
Magnus TörnblomDepartment of Surgery, Visby Hospital, Visby, Sweden; View further author information
&
Pär StattinDepartment of Surgical Sciences, Uppsala University Hospital, Uppsala, SwedenView further author information
Pages 227-234 | Received 20 Jan 2020, Accepted 12 Apr 2020, Published online: 04 May 2020

References

  • Sartor O, de Bono JS. Metastatic prostate cancer. N Engl J Med. 2018;378(7):645–657.
  • Nuhn P, De Bono JS, Fizazi K, et al. Update on systemic prostate cancer therapies: Management of metastatic castration-resistant prostate cancer in the era of precision oncology. Eur Urol. 2019;75(1):88–99.
  • Saturni S, Bellini F, Braido F, et al. Randomized controlled trials and real life studies. Approaches and methodologies: a clinical point of view. Pulm Pharmacol Ther. 2014; 27(2):129–138.
  • National Prostate Cancer Register. [cited 2020 Jan 9]. Available from: https://www.npcr.se.
  • Hagel E, Garmo H, Bill-Axelson A, et al. PCBaSe Sweden: a register-based resource for prostate cancer research. Scand J Urol Nephrol. 2009;43(5):342–349.
  • Van Hemelrijck M, Garmo H, Wigertz A, et al. Cohort profile update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base–a refined prostate cancer trajectory. Int. J. Epidemiol. 2016;45(1):73–82.
  • Stattin P, Sandin F, Sandbäck T, et al. Dashboard report on performance on select quality indicators to cancer care providers. Scand J Urol. 2016;50(1):21–28.
  • Stattin P, Sandin F, Loeb S, et al. Public online reporting from a nationwide population-based clinical prostate cancer register. BJU Int. 2018;122(1):8–10.
  • Oken M, Creech R, Tormey D, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–655.
  • The Eastern Cooperative Oncology Group/World Health Organization Performance Status. [cited 2020 Jan 9]. Available from: https://www.mdcalc.com/
  • Groenvold M, Petersen MA, Aaronson NK, et al. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer. 2006; 42(1):55–64.
  • EQ5D. [cited 2020 Jan 9]. Available from: https://euroqol.org.
  • Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736.
  • Parker C, Nilsson S, Heinrich D, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213–223.
  • James S, Rao SV, Granger CB. Registry-based randomized clinical trials–a new clinical trial paradigm. Nat Rev Cardiol. 2015;12(5):312–316.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.